Drug-Eluting Stent Market Report: Trends, Forecast and Competitive Analysis to 2030

Drug-Eluting Stent Trends and Forecast

The future of the global drug-eluting stent market looks promising with opportunities in the coronary artery disease and peripheral artery disease markets. The global drug-eluting stent market is expected to reach an estimated $12.8 billion by 2030 with a CAGR of 6.3% from 2024 to 2030. The major drivers for this market are increasing global elderly population and rising incidence of cardiovascular disorders.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Drug-Eluting Stent by Segment

The study includes a forecast for the global drug-eluting stent by coating type, application, and region.

Drug-Eluting Stent Market by Coating Type [Shipment Analysis by Value from 2018 to 2030]:

• Polymer-Based Coating
• Polymer-Free Coating

Drug-Eluting Stent Market by Application [Shipment Analysis by Value from 2018 to 2030]:

• Coronary Artery Disease
• Peripheral Artery Disease

Drug-Eluting Stent Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Drug-Eluting Stent Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies drug-eluting stent companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the drug-eluting stent companies profiled in this report include-

• Boston Scientific
• Medtronic
• Abbott Laboratories
• Biosensors
• Biotronik
• Lepu Medical Technology
• Terumo Medical
• Cook Medical
• Shandong JW Medical Systems
• B.Braun

Drug-Eluting Stent Market Insights

Lucintel forecasts that polymer-based coatings will remain larger segment over the forecast period due to its proven effectiveness and adaptability.

Within this market, coronary artery disease will remain larger segment due to increasing global incidence of coronary artery disease.

North America will remain the largest region over the forecast period due to presence of well-developed healthcare infrastructure and widespread adoption of advanced medical technologies in the region.

Features of the Global Drug-Eluting Stent Market

Market Size Estimates: Drug-eluting stent market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Drug-eluting stent market size by coating type, application, and region in terms of value ($B).

Regional Analysis: Drug-eluting stent market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different coating types, applications, and regions for the drug-eluting stent market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the drug-eluting stent market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the drug-eluting stent market size?

Answer: The global drug-eluting stent market is expected to reach an estimated $12.8 billion by 2030.

Q2. What is the growth forecast for drug-eluting stent market?

Answer: The global drug-eluting stent market is expected to grow with a CAGR of 6.3% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the drug-eluting stent market?

Answer: The major drivers for this market are increasing global elderly population and rising incidence of cardiovascular disorders.

Q4. What are the major segments for drug-eluting stent market?

Answer: The future of the drug-eluting stent market looks promising with opportunities in the coronary artery disease and peripheral artery disease markets.

Q5. Who are the key drug-eluting stent market companies?

Answer: Some of the key drug-eluting stent companies are as follows:

• Boston Scientific
• Medtronic
• Abbott Laboratories
• Biosensors
• Biotronik
• Lepu Medical Technology
• Terumo Medical
• Cook Medical
• Shandong JW Medical Systems
• B.Braun

Q6. Which drug-eluting stent market segment will be the largest in future?

Answer: Lucintel forecasts that polymer-based coatings will remain larger segment over the forecast period due to its proven effectiveness and adaptability.

Q7. In drug-eluting stent market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to presence of well-developed healthcare infrastructure and widespread adoption of advanced medical technologies in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the drug-eluting stent market by coating type (polymer-based coating and polymer-free coating), application (coronary artery disease and peripheral artery disease), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?